Enabling a new model for healthcare with AI co-clinician
DeepMind has published a blog post outlining research into an AI co-clinician concept aimed at augmenting clinical care. The post describes a vision for AI-augmented healthcare where AI systems work alongside medical professionals. The content appears to be a high-level research direction announcement rather than a specific model or product release.
Related guides (3)
Related events (8)
Accelerating discovery of liver disease mechanisms with Co-Scientist
DeepMind's Co-Scientist AI system is being used by researcher Filippo Menolascina to identify new treatment mechanisms for liver disease and explain differential drug response across patients. The application demonstrates Co-Scientist's utility in biomedical hypothesis generation and drug discovery workflows. This represents a concrete scientific use case for AI-assisted research in a clinical domain.
Finding the molecular switches behind new infectious diseases
DeepMind's Co-Scientist AI tool is being used by researcher Clare Bryant to identify genetic triggers in emerging infectious diseases. The application demonstrates Co-Scientist's utility in accelerating biological discovery, specifically in understanding molecular mechanisms underlying new pathogens. This represents a concrete scientific use case for AI-assisted research in infectious disease biology.
Opening new paths in aging research: Calico uses DeepMind Co-Scientist
Calico Life Sciences is applying DeepMind's Co-Scientist AI system to aging research, using it to synthesize dispersed scientific findings and generate novel research leads. The collaboration represents a deployment of AI-assisted scientific discovery in a longevity biology context. This is a real-world application case for Co-Scientist, DeepMind's AI system designed to accelerate scientific research workflows.
MedGemma: DeepMind releases most capable open models for health AI development
Google DeepMind has announced new multimodal models in the MedGemma collection, described as their most capable open models for health AI development. The release expands the MedGemma family with enhanced multimodal capabilities targeting medical and clinical AI applications. As open models, they are intended to support developers building health AI systems.
MIT Technology Review: Agentic AI as a solution to global health care strain
MIT Technology Review publishes a commentary arguing that agentic AI could help address systemic pressures in global health care, including chronic underinvestment, staff burnout, and fragmented access to care. The piece frames agentic AI as a potential tool for 'rehumanizing' care delivery rather than replacing human workers. The article is a high-level industry analysis piece without specific technical claims or product announcements.
OpenAI and Penda Health debut AI clinical copilot with 16% diagnostic error reduction
OpenAI has partnered with Penda Health to deploy an AI clinical copilot in real-world healthcare settings. The system reportedly reduces diagnostic errors by 16%, representing a concrete outcome metric from a live deployment rather than a controlled trial. This marks a notable enterprise deployment of OpenAI technology in African healthcare infrastructure.
OpenAI for Healthcare
OpenAI has launched a dedicated healthcare vertical offering called OpenAI for Healthcare, targeting enterprise customers with HIPAA-compliant AI capabilities. The initiative aims to reduce administrative burden and support clinical workflows. This represents OpenAI's formal entry into the regulated healthcare enterprise market.
AI-Native Healthcare: Abridge on 100M Doctor Visits, Clinician Time Savings, and Prior Auth Automation
Latent Space interviews Abridge co-founders Janie Lee and Chai Asawa about their AI-native healthcare platform that has processed 100 million doctor visits. The system converts patient-clinician conversations into structured clinical documentation, reportedly saving clinicians 10-20 hours per week. The platform also automates prior authorization workflows, reducing turnaround from days to minutes.